ascopubs.org6d
COSMIC-021 Phase Ib Study of Cabozantinib Plus Atezolizumab: Results from the Locally Advanced or Metastatic Urothelial Carcinoma Cohorts
Co-Occurrence of Cytogenetic Abnormalities and High-Risk Disease in Newly Diagnosed and Relapsed/Refractory Multiple Myeloma A total of 121 patients (previous ICI-treated cohort, n = 31, and each of ...
ascopubs.org5d
Socioeconomic Burden of Ovarian Cancer in 11 Countries
Survival and Its Predictors Among Patients Receiving Transarterial Chemoembolization for Hepatocellular Carcinoma in Ethiopia: A 6-Year Follow-Up Study Ovarian cancer remains among the most aggressive ...
ascopubs.org6d
Reply to: Enfortumab Vedotin: A Promising Therapy for Head and Neck Cancer With Potential Links to Human Papillomavirus
The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...
ascopubs.org2d
Management of relapsed primary retroperitoneal (RP) germ-cell tumor (GCT) after front-line chemotherapy.
Therapeutic approaches and outcomes in patients aged 50+ with germ cell tumours. Survival outcomes by salvage chemotherapy received.
ascopubs.org2d
Survival outcomes of testicular cancer (TC) in Hispanic men based on analyses from the National Cancer Database (NCDB).
Assessing racial disparities in testicular cancer survival: Evidence from a nationwide cohort. This is an ASCO Meeting Abstract from the 2025 ASCO Genitourinary Cancers Symposium. This abstract does ...
ascopubs.org2d
Germline correlates of clinical outcomes in aggressive prostate cancer subtypes treated with radiation therapy.
Genomic alterations in intraductal prostate cancer: Insights from the Genomic Umbrella Neoadjuvant study (GUNS) in high-risk localized disease. This is an ASCO Meeting Abstract from the 2025 ASCO ...
ascopubs.org2d
Whole-slide multiplexed tissue imaging of prostate adenocarcinoma to investigate immune niches in high- versus low-grade tumors.
Developing a deep learning algorithm for automated p53 immunohistochemistry digital image analysis in prostate cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Genitourinary Cancers ...
ascopubs.org5d
Oral Immune-Related Adverse Events Secondary to Immune Checkpoint Inhibitors: Call to Action
Perspectives of Lymphoma Survivors and Oncology Care Providers on Survivorship Care: A Qualitative Study Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment, offering new hope ...
ascopubs.org6d
Leveraging tumor organoids to model drug response in clear cell renal cell carcinoma.
Validation of a 15-gene prognostic signature in metastatic clear cell renal cell carcinoma. This is an ASCO Meeting Abstract from the 2025 ASCO Genitourinary Cancers Symposium. This abstract does not ...
ascopubs.org2d
Evaluating an integrated germline polygenic and clinical risk model (P-CARE) specifically for aggressive prostate cancer.
Evaluating RSPO2 activation and its association with outcomes and potential role as a driver in double-negative prostate cancer (DNPC). This is an ASCO Meeting Abstract from the 2025 ASCO ...
ascopubs.org5d
Radiomics and Deep Learning Prediction of Immunotherapy-Induced Pneumonitis From Computed Tomography
Primary barriers to application of immune checkpoint inhibitor (ICI) therapy for cancer include severe side effects (such as potentially life threatening pneumonitis [PN]), which can cause the ...